SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genomic Valley Biotech informs about newspaper publication

08 Dec 2022 Evaluate
Genomic Valley Biotech has informed about Newspaper Advertisements published for Notice of Annual General Meeting, E-Voting Information and Book Closure in the newspapers, Financial Express (English Edition), and Jansatta (Hindi Edition) on 08th December, 2022.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

28.80 0.00 (0.00%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1512.00
Mangalam Global Ent 12.70
Kaveri Seed 929.20
Regaal Resources 81.43
Simran Farms 156.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×